1y return+100.4%S&P 500 +20.9%
3y return+138.2%S&P 500 +68.5%
5y return−19.1%S&P 500 +74.5%
These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.
$100 invested in its stock picks
Since December 31, 2020: $80 against $200 in the S&P 500.2
Blue Water Life Science Advisors, LPS&P 500 (SPY)
Top holdings
At the end of June 30, 2026. Change is in shares since the quarter before.2
| Stock | Value | Share of portfolio | Change |
|---|---|---|---|
| CDNACaredx Inc | $33.9M | 21.4% | +27.3% |
| TXG10x Genomics Inc | $24.6M | 15.5% | −41.1% |
| PSNLPersonalis Inc | $22.5M | 14.1% | |
| ADPTAdaptive Biotechnologies Cor | $21.7M | 13.6% | |
| GHGuardant Health Inc | $17.2M | 10.8% | −52.6% |
| QTRXQuanterix Corp | $15.0M | 9.5% | +62.2% |
| NTRANatera Inc | $9.4M | 5.9% | −23.0% |
| BLLNBilliontoone Inc | $8.4M | 5.3% | +250.0% |
| TEMTempus Ai Inc | $6.1M | 3.8% | −32.6% |
Best picks still held
How each current holding has done since the quarter it first appeared in its filings (up to six years back).
| Stock | Held since | Return since | Now worth |
|---|---|---|---|
| ADPTAdaptive Biotechnologies Cor | September 30, 2024 | +318.9% | $21.7M |
| NTRANatera Inc | December 31, 2020 | +172.8% | $9.4M |
| PSNLPersonalis Inc | September 30, 2024 | +149.1% | $22.5M |
| CDNACaredx Inc | June 30, 2024 | +83.5% | $33.9M |
| TXG10x Genomics Inc | March 31, 2026 | +80.6% | $24.6M |
| BLLNBilliontoone Inc | March 31, 2026 | +52.0% | $8.4M |
| GHGuardant Health Inc | December 31, 2020 | +16.4% | $17.2M |
| TEMTempus Ai Inc | September 30, 2025 | −28.2% | $6.1M |
| QTRXQuanterix Corp | December 31, 2023 | −84.2% | $15.0M |
Sold off last quarter
- TWSTTwist Bioscience Corp was $13.1M
Quarter by quarter
| Quarter | Its picks | S&P 500 |
|---|---|---|
| June 30, 2026 | +68.5% | +14.8% |
| March 31, 2026 | −12.3% | −4.6% |
| December 31, 2025 | +29.6% | +2.4% |
| September 30, 2025 | +4.7% | +7.8% |
| June 30, 2025 | +25.6% | +10.5% |
| March 31, 2025 | −1.7% | −4.6% |
| December 31, 2024 | +3.2% | +2.1% |
| September 30, 2024 | +17.4% | +5.4% |
| June 30, 2024 | −5.3% | +4.0% |
| March 31, 2024 | −0.3% | +10.0% |
| December 31, 2023 | +11.7% | +11.2% |
| September 30, 2023 | −24.8% | −3.6% |
| June 30, 2023 | −9.0% | +8.3% |
| March 31, 2023 | +2.8% | +7.0% |
| December 31, 2022 | −21.4% | +7.1% |
| September 30, 2022 | +7.5% | −5.3% |
| June 30, 2022 | −29.1% | −16.5% |
| March 31, 2022 | −29.0% | −4.9% |
| December 31, 2021 | −9.3% | +10.7% |
| September 30, 2021 | −6.0% | +0.3% |
Sources
Every number on this page points here. Each one links to the public record.
- 1SEC EDGAR: Blue Water Life Science Advisors, LP Form 13F filingshttps://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1789778&type=13F-HR&dateb=&owner=include&count=40CIK 1789778
- 2SEC: 13F for the quarter ended June 30, 2026https://www.sec.gov/Archives/edgar/data/1789778/000142050626001647/Filed August 14, 2026 · accession 0001420506-26-001647